Influenza B virus Nucleoprotein antibody
GTX128538
ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry
Product group Antibodies
ReactivityVirus
Overview
- SupplierGeneTex
- Product NameInfluenza B virus Nucleoprotein antibody
- Delivery Days Customer9
- Application Supplier NoteWB: 1:5000-1:20000. ICC/IF: 1:100-1:2000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration0.4 mg/ml
- ConjugateUnconjugated
- HostRabbit
- IsotypeIgG
- ReactivityVirus
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Gravel C, Muralidharan A, Duran A, et al. Synthetic vaccine affords full protection to mice against lethal challenge of influenza B virus of both genetic lineages. iScience. 2021,24(11):103328. doi: 10.1016/j.isci.2021.103328Read this paper
- Zhang Z, Zhang H, Xu L, et al. Selective usage of ANP32 proteins by influenza B virus polymerase: Implications in determination of host range. PLoS Pathog. 2020,16(10):e1008989. doi: 10.1371/journal.ppat.1008989Read this paper
- Jang Y, Lee HW, Shin JS, et al. Antiviral activity of KR-23502 targeting nuclear export of influenza B virus ribonucleoproteins. Antiviral Res. 2016,134:77-88. doi: 10.1016/j.antiviral.2016.07.024Read this paper

![ICC/IF analysis of MDCK cells infected with Influenza B virus using GTX00707 Influenza B virus Nucleoprotein antibody [8C8] Upper : The cells infected with an Influenza B virus vaccine strain, Malaysia/2506/2004 as a representative of Victoria group. Lower : The cells infected with an Influenza B virus vaccine strain, Florida/4/2006 as Yamagata group. Fixation : 4% PFA in PBS Permeabilization : 0.1% Triton X-100 in PBS](https://www.genetex.com/upload/website/prouct_img/normal/GTX00707/GTX00707_20191104_ICC-IF_w_23053121_616.webp)